Progressive Multifocal Leukoencephalopathy Unmasked by Teclistamab in a Refractory Multiple Myeloma Patient

Progressive Multifocal Leukoencephalopathy Unmasked by Teclistamab in a Refractory Multiple Myeloma Patient

This case report describes the development of Progressive Multifocal Leukoencephalopathy (PML) in a 72-year-old male with relapsed/refractory multiple myeloma (RRMM), following a single dose of teclistamab amidst a COVID-19 infection. Shortly after starting teclistamab treatment, the patient develop...

Full description

Bibliographic Details
Main Authors: Panos Arvanitis, Dimitrios Farmakiotis, Ari Pelcovits
Format: Article
Language:English
Published: MDPI AG 2024-05-01
Series:Current Oncology
Subjects:
multiple myeloma
Progressive Multifocal Leukoencephalopathy
teclistamab
bispecific antibodies
Online Access:https://www.mdpi.com/1718-7729/31/5/202

Internet

https://www.mdpi.com/1718-7729/31/5/202

Similar Items